ETBI
EastGate Biotech Corp. is a pharmaceutical company. The Company produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. It utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The Company develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). It has its offices in New York, London SF, Cockfosters BP, Los Angeles, Chicago and Las Vegas.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2017 Q3 | -0.00 | $23,138 | -$1M |
| 2017 Q2 | -0.00 | $114,500 | -$131,034 |
| 2017 Q1 | -0.00 | $0 | -$121,479 |
| 2016 Q4 | -0.00 | -$93,525 | -$168,354 |
| 2016 Q3 | -0.00 | $1,689 | -$107,442 |
| 2016 Q2 | -0.00 | $90,751 | -$10,180 |
| 2016 Q1 | -0.00 | $1,085 | -$103,502 |
| 2015 Q4 | -0.00 | $303 | -$18,375 |